Aequus Pharmaceuticals Inc. (TSXV:AQS)
Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Apr 25, 2025, 9:30 AM EST

Aequus Pharmaceuticals Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.920.580.251.382.712.59
Revenue Growth
122.30%129.21%-81.53%-49.17%4.71%58.81%
Gross Profit
0.520.330.141.282.672.59
Operating Income
-0.57-2.13-2.82-2.58-1.61-0.78
Net Income
-0.66-2.18-2.96-3.21-1.81-1.05
Earnings Per Share
-0.00-0.02-0.02-0.02-0.01-0.01
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
0.010.050.170.252.441.72
Total Debt
6.036.615.062.782.182.32
Net Cash (Debt)
-6.02-6.56-4.89-2.530.26-0.6
Net Cash Growth
------
Net Cash Per Share
-0.05-0.05-0.04-0.020.00-0.01

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-0.12-1.66-2.29-1.95-1.17-0.8
Capital Expenditures
-----0-0.01
Free Cash Flow
-0.12-1.66-2.29-1.95-1.18-0.82
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
56.95%56.88%56.36%92.49%98.42%100.00%
Operating Margin
-62.50%-364.10%-1106.45%-187.17%-59.22%-30.08%
Pretax Margin
-71.46%-372.74%-1163.11%-232.65%-66.66%-40.32%
Profit Margin
-71.46%-372.74%-1163.11%-232.65%-66.66%-40.32%
FCF Margin
-12.61%-283.44%-899.97%-141.51%-43.33%-31.52%

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
0.722.2713.013.365.625.18